Aethlon Medical, Inc.
AEMD
$1.65
-$0.04-2.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.34M | 7.09M | 8.51M | 9.34M | 10.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.34M | 7.09M | 8.51M | 9.34M | 10.70M |
| Operating Income | -7.34M | -7.09M | -8.51M | -9.34M | -10.70M |
| Income Before Tax | -11.52M | -11.26M | -12.58M | -13.39M | -9.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.52 | -11.26 | -12.58 | -13.39 | -9.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.52M | -11.26M | -12.58M | -13.39M | -9.56M |
| EBIT | -7.34M | -7.09M | -8.51M | -9.34M | -10.70M |
| EBITDA | -7.01M | -6.76M | -8.18M | -9.00M | -10.35M |
| EPS Basic | -49.09 | -56.69 | -69.06 | -88.16 | -127.83 |
| Normalized Basic EPS | -30.63 | -35.38 | -43.16 | -55.10 | -96.55 |
| EPS Diluted | -49.09 | -56.69 | -69.06 | -88.16 | -127.83 |
| Normalized Diluted EPS | -30.63 | -35.38 | -43.16 | -55.10 | -96.55 |
| Average Basic Shares Outstanding | 1.61M | 961.40K | 738.10K | 623.70K | 474.60K |
| Average Diluted Shares Outstanding | 1.61M | 961.40K | 738.10K | 623.70K | 474.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |